...
首页> 外文期刊>Vaccine >Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein
【24h】

Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein

机译:用炭疽毒素融合蛋白处理的树突状细胞免疫诱导小鼠丙型肝炎病毒特异性细胞毒性T淋巴细胞

获取原文
获取原文并翻译 | 示例
           

摘要

As a novel and safe vaccine strategy, the anthrax toxin-mediated antigen delivery system composed of lethal factor (LF) fusion protein and protective antigen (PA) has been studied to prime hepatitis C virus (HCV) core-specific cytotoxic T lymphocytes (CTLs) in vivo. The core epitope fused to LF (LF-core) tocrether with PA induces a negligible core-specific CTL response in mice, whereas core-specific CTL are effectively primed in mice by injecting dendritic cells (DCs) treated in vitro with LF-core and PA. These findings imply that LF fusion protein plus PA in combination with dendritic cells may be useful for a novel T cell vaccine against HCV infection.
机译:作为一种新颖且安全的疫苗策略,已研究了由致死因子(LF)融合蛋白和保护性抗原(PA)组成的炭疽毒素介导的抗原递送系统,用于感染丙型肝炎病毒(HCV)核心特异性细胞毒性T淋巴细胞(CTL) )体内。用PA与LF(LF-core)融合的核心表位在小鼠中诱导的核心特异性CTL反应可忽略不计,而通过注射在体外用LF-core和DC处理的树突状细胞(DC)可以有效地在小鼠中引发核心特异性CTL反应。 PA这些发现表明,LF融合蛋白加PA与树突状细胞的结合可能对抗HCV感染的新型T细胞疫苗有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号